Mary Ann Hodorowicz, RDN, CDE, gives a preview of her upcoming Cardiometabolic Risk Summit talk on what clinicians can do to provide high-quality outpatient services related to cardiometabolic health, as...
Mary Ann Hodorowicz, RDN, CDE, gives a preview of her upcoming Cardiometabolic Risk Summit talk on what clinicians can do to provide high-quality outpatient services related to cardiometabolic health, as...
In his session at this year's Cardiometabolic Risk Summit, Dr Grumet discusses how sharing your story with patients via social media and other avenues can help bridge the intimacy gap.
In this podcast, Robert P. Giugliano, MD, discusses the safety and efficacy findings from IMPROVE-IT, the practical implications for ezetimibe, and more.
She talks about evaluating obesity medications, her tips for choosing the right medication for the right patient, and medications that are on the horizon. This is also the topic of her session at our...
In this podcast, Dr Bruce Lee from the Global Obesity Prevention Center at Johns Hopkins talks about the many contributing factors to childhood obesity as well as possible solutions to the growing...
In this commentary, Yehuda Handelsman, MD, deconstructs the common misconception that glucose control is the only important factor for managing diabetes and CVD.
In this podcast, Peter Reaven, MD, discusses the effects of glucose variability on vascular disease outcomes, the results of the ACCORD and VADT trials, and how the trials' results have impacted clinical...
